Sorrento Therapeutics Inc

NASDAQ:SRNE   3:59:40 PM EDT
6.99
-0.30 (-4.05%)
5:16:43 PM EDT: $6.96 -0.03 (-0.36%)
Products

Sorrento Therapeutics And Viralclear Enter Into Agreement To Explore Combination Antibody Plus Antiviral Therapy Against Covid-19

Published: 09/30/2020 13:19 GMT
Sorrento Therapeutics Inc (SRNE) - Sorrento Therapeutics and Viralclear Enter Into Agreement to Explore Combination Antibody Plus Antiviral Therapy Against Covid-19.
Sorrento Therapeutics Inc - to Initially Make Available Sti-1400 Neutralizing Antibody Candidate for Testing.
Sorrento Therapeutics Inc - Viralclear to Contribute Its Oral Antiviral Merimepodib (impdh Inhibitor).
Sorrento Therapeutics Inc - Agreement Will Allow for Testing of Merimepodib With Neutralizing Antibodies in Golden Syrian Hamster Model of Covid-19.